	Hippo-YAP/TAZ signaling in gastric cancer: molecular pathogenesis and emerging therapeutic horizons. Med Oncol Kaur M, Mungurere RF, Mitinje N, Sethi GK, Kaur AS, Mishra A. PMID: 41656414 [PubMed - indexed for MEDLINE]
	Therapeutic targeting of FZD receptor proteins with biologics in cancer. Drug Discov Today Hmila I, Katanaev VL. PMID: 41655894 [PubMed - as supplied by publisher]
	IUPHAR review: Pathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia/reperfusion injury. Pharmacol Res Sultana S, Xie Y, Kamal MS, Li W. PMID: 41655822 [PubMed - as supplied by publisher]
	The RAS testing in real world management of metastatic colorectal cancer: the results of Italian Laboratories Survey. Crit Rev Oncol Hematol Pinto C, Malapelle U, Fassan M, Maiello E, Martinelli E, Sartore-Bianchi A, Annibali V, Marchetti A, Normanno N. PMID: 41655752 [PubMed - as supplied by publisher]
	Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol Nilsson P, Gunnlaugsson A, Beckman L, Widmark A, Fransson P, Hoyer M, Lagerlund M, Kindblom J, Johansson B, Björnlinger K, Ginman C, Olsson M, Agrup M, Kjellén E, Zackrisson B, Tavelin B, Franzén L, Anderson H, Thellenberg Karlsson C. PMID: 41655576 [PubMed - as supplied by publisher]
	The role of general practitioners in managing patient participation in the National Bowel Cancer Screening Program: A qualitative study. Aust J Gen Pract Bulsara C, Arnold-Reed D, Gaspar J, Taylor K, Williams A. PMID: 41655292 [PubMed - indexed for MEDLINE]
	LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review. Clin Exp Med Vanan AG, Hassanzadeh F, Ghorbaninezhad F, Taheri F, Bahrami O, Heidari P, Baharvand Z, Raissi S, Eini P, Tahmasebi S, Safarzadeh E. PMID: 41655184 [PubMed - as supplied by publisher]
	cGAS-STING Pathway in Gastrointestinal Malignancies: Mechanistic Insights and Translational Therapeutic Opportunities. J Gastrointest Cancer Rathod H, Jain P, Dharme KK, Ajazuddin. PMID: 41655160 [PubMed - indexed for MEDLINE]
	Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer. Cell Commun Signal Luo X, Cui J, Shi J, Sun G, Zhang L, Li Y, Guo Y, Kuai L, Sun T, Luo Q, Cai J, An Q, Zhang W, Xiao F, Zhao G. PMID: 41654905 [PubMed - as supplied by publisher]
	Comparison of timing for early postoperative intake in patients with upper gastrointestinal cancer: a network meta-analysis. BMC Surg Yang Z, Fan Y, Wei J, Nan L, Li Q. PMID: 41654844 [PubMed - as supplied by publisher]
	Neoadjuvant therapy and the Watch and Wait strategy in rectal cancer diagnosed after sex reassignment surgery. Cir Esp (Engl Ed) Ibáñez N, Abrisqueta J, Encarnación JA, Hernández Q. PMID: 41654118 [PubMed - as supplied by publisher]
	Precision oncology in Bulgaria: a prospective study of metastatic colorectal cancer patients. Cancer Treat Res Commun Dimitrov G, Kamburova Z, Petrov K, Dimitrov D, Popovska S. PMID: 41653877 [PubMed - as supplied by publisher]
	CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer. Transl Oncol Rajamanickam V, Simons ND, Rosales W, Kravchenko A, Yamazaki T, Bernard B, Piening B, Domingo E, Maughan T, Alvarez-Jimenez C, Desilvio T, Viswanath S, Whiteford M, Hayman A, O'Brien D, Kiely MX, Ahmad R, Gough MJ, Crittenden MR, Young KH. PMID: 41653703 [PubMed - as supplied by publisher]
	Cancer survival in Italian patients diagnosed between 2008 and 2017. Cancer Epidemiol Capocaccia R, Fusco M, Zarcone M, Fruscione S, Pesce MT, Stracci F, Mazzucco W, AIRTUM Working Group, Graziano G, Mazzola S, Minichino A, Sessa A, Tumino R, Colanino AZ, Candela G, Loperto I, Vitale F, Abbate R, Clemente SV, Vincenzi R, Piras D, Porcheddu A, Gasparotti C, Maifredi G, Pinna P, Zollo E, Ciullo V, Baracco S, Napolioni V, Manasse S, Eugenia S, Usticano A, Caldarella A, Turi A, Santelli E, Galasso R, Riccio LD, Martinelli L, Mantovani W, Serraino D, Maso LD, Ferrante M, Migliore E, Leite S, Villa M, Casella C, Russo AG, Negrino L, D'orsi G, Manzoni F, Bruni R, Castelli M, Gambino M, Cavallo R, Fametti AC, Ghisleni S, Sampietro G. PMID: 41653505 [PubMed - as supplied by publisher]
	Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): Results from the GASPAR phase 2 study. Eur J Cancer Dos Santos M, Lequesne J, Piessen G, Leconte A, Guimbaud R, Pernot S, Bouche O, Hiret S, Soularue E, Tougeron D, Dahan L, Le Sourd S, Borg C, Samalin E, Corbinais S, Parzy A, Guilloit JM, Varatharajah S, Brachet PE, Dorbeau M, Galais MP, Desgrippes R, Clarisse B. PMID: 41653501 [PubMed - as supplied by publisher]
	Safety and Feasibility of Long-Term High-Intensity Interval Training With and Without Peer Support in Cancer Survivors. Scand J Med Sci Sports Adlard KN, Farley MJ, Boytar AN, Salisbury CE, Bolam KA, Pegg DK, Aitken JF, Chambers SK, Dunn JC, Courneya KS, Jenkins DG, Skinner TL. PMID: 41653429 [PubMed - indexed for MEDLINE]
	Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain. Clin Transl Oncol Romero Zoghbi SE, López Campos F, Ocanto A, Sanz-Rosa D, Thuissard-Vasallo IJ, Andreu Vázquez C, Laria C, Fernández Ibiza J, Andreescu Yagüe J, Krumina E, Mateos M, Dzhugashvili M, Glaría LA, Gonsalves D, Fernández C, Esteban D, de la Fuente JB, González Ferreira JA, Ristori A, Rivas D, López E, Bezares Alarcón AB, Aakki L, Larrea L, García Cuesta JÁ, Zamboglou C, Alongi F, García García R, Couñago F. PMID: 41653361 [PubMed - as supplied by publisher]
	A new, machine learning-based approach to metastatic neuroendocrine tumors of unknown origin. J Neuroendocrinol Lü J, Amin T, Clauditz T, Steinkraus K, Buchstab O, Huber S, Izbicki J, Fründt T, Schrader J, Werner R, Schmitz R. PMID: 41652828 [PubMed - indexed for MEDLINE]
	Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study. Nutr Clin Pract Klassen PN, Kim CA, Kasnik J, Sawyer MB, Ghosh S, Baracos V, Mazurak VC. PMID: 41652656 [PubMed - as supplied by publisher]
	Comparison of the safety and efficacy of different neoadjuvant therapy cycles for locally advanced gastric cancer: a retrospective propensity score-matched cohort study. World J Surg Oncol Ren Z, Tang J, Xu H, Hou S, Wang Y, Hou Z, Qu H. PMID: 41652463 [PubMed - as supplied by publisher]

Articles 1 - 20 / 236011

Page 1 of 11801



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy